Pfizer (PFE) Net Margin (2009 - 2026)
Pfizer (PFE) reported Net Margin of 0.56% for Q1 2026, down 150.53% on a QoQ basis from 1.1% in Q2 2025.
Pfizer (PFE) has 18 years of Net Margin data on file, last reported at 0.56% in Q1 2026.
- Quarterly Net Margin changed N/A year-over-year to 0.56% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.05% (up 2.0% YoY) and the FY2025 annual result came in at 0.04%, down 9.0% from the prior year.
- Net Margin fell to 0.56% in Q1 2026 per PFE's latest filing, from 1.1% in the prior quarter.
- Across five years, Net Margin topped out at 1.1% in Q2 2025 and bottomed at 1.81% in Q3 2024.
- The 5-year median for Net Margin is 0.03% (2022), against an average of 0.1%.
- The widest annual swing landed in 2022, when Net Margin surged 137 bps; it then tumbled 254 bps in 2024.
- Tracing PFE's Net Margin over 5 years: stood at 0.09% in 2022, then sank by 716 bps to 0.76% in 2023, then tumbled by 139 bps to 1.81% in 2024, then soared by 161 bps to 1.1% in 2025, then slumped by 151 bps to 0.56% in 2026.
- Per Business Quant, the three latest PFE Net Margin figures stand at 0.56% (Q1 2026), 1.1% (Q2 2025), and 1.81% (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 37.36% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 21.76% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 4.65% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -25.84% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 21.11% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 29.04% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -0.56% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 23.32% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -0.56% |
| Jun 29, 2025 | 1.10% |
| Sep 29, 2024 | -1.81% |
| Jun 30, 2024 | 0.13% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.76% |
| Oct 1, 2023 | 0.73% |
| Jul 2, 2023 | -0.06% |
| Apr 2, 2023 | 0.03% |
| Oct 2, 2022 | -0.09% |
| Jul 3, 2022 | 0.12% |
| Apr 3, 2022 | -0.04% |
| Oct 3, 2021 | -0.05% |
| Jul 4, 2021 | -1.25% |
| Apr 4, 2021 | 0.01% |
| Sep 27, 2020 | 5.45% |
| Jun 28, 2020 | 9.05% |
| Mar 29, 2020 | 8.74% |
| Sep 29, 2019 | 0.03% |
| Dec 31, 2018 | 633.59% |
| Sep 30, 2018 | 0.08% |
| Apr 1, 2018 | -0.01% |
| Dec 31, 2017 | 0.01% |
| Jul 2, 2017 | 0.02% |
| Dec 31, 2016 | 0.12% |
| Jul 3, 2016 | 0.01% |
| Dec 31, 2015 | -0.14% |
| Sep 27, 2015 | 0.07% |
| Jun 28, 2015 | 0.01% |
| Mar 29, 2015 | 0.05% |
| Dec 31, 2014 | -0.11% |
| Sep 28, 2014 | -0.02% |
| Mar 30, 2014 | 0.64% |
| Dec 31, 2013 | -0.42% |
| Sep 29, 2013 | 0.09% |
| Jun 30, 2013 | 81.39% |
| Mar 31, 2013 | 1.20% |
| Dec 31, 2012 | 29.15% |
| Sep 30, 2012 | 1.74% |
| Apr 1, 2012 | 0.53% |
| Dec 31, 2011 | 15.83% |
| Oct 2, 2011 | 0.58% |
| Jul 3, 2011 | 0.59% |
| Apr 3, 2011 | 0.06% |
| Dec 31, 2010 | -0.61% |
| Oct 3, 2010 | 0.16% |
| Jul 4, 2010 | 0.18% |
| Apr 4, 2010 | 0.11% |
| Dec 31, 2009 | 0.07% |
| Sep 27, 2009 | 0.02% |
| Jun 28, 2009 | 0.03% |
| Mar 29, 2009 | 0.01% |